COYA-303

N/A

Report date: 2025/04/16 16:57:00

Base Information

Drug NameCOYA-303
Drug Alias NameCOYA 301+GLP-1 receptor agonistCOYA-303
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionRegulatory T-lymphocytes stimulantsGlucagon-like peptide 1 receptor agonistsInterleukin-2 replacements
TargetsGlucagon-like peptide 1 receptorInterleukin-2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes COYA-301
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A